Liraglutide 3.0 mg reduces body weight and improves cardiometabolic risk factors in overweight/obese adults: the SCALE obesity and prediabetes randomised trial

被引：0
|
作者：
Krempf, M. [1 ]
Astrup, A. [2 ]
le Roux, C. [3 ]
Fujioka, K. [4 ]
Greenway, F. [5 ]
Halpern, A. [6 ]
Lau, D. C. W. [7 ]
Violante Ortiz, R. [8 ]
Wilding, J. P. H. [9 ]
Jensen, C. B. [10 ]
Lillleore, S. K. [10 ]
Pi-Sunyer, X. [11 ]
机构：
[1] CHRU Nantes, Clin Endocrinol, Nantes, France
[2] Univ Copenhagen, DK-1168 Copenhagen, Denmark
[3] Univ Coll Dublin, Dublin, Ireland
[4] Scripps Clin, La Jolla, CA USA
[5] Louisiana State Univ, Baton Rouge, LA 70803 USA
[6] Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil
[7] Univ Calgary, Calgary, AB T2N 1N4, Canada
[8] Inst Mexicano Seguro Social, Ciudad Madero, Mexico
[9] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
[10] Novo Nordisk AS, Soborg, Denmark
[11] Columbia Univ, New York, NY USA
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
903
引用
收藏
页码：S368 / S368
页数：1
相关论文
共 50 条
  • [41] Liraglutide 3.0 mg for Weight Management in Obese/Overweight Adults with Type 2 Diabetes: Results from the SCALE™ Diabetes 56-Week Randomized, Double-Blind, Placebo-Controlled Trial
    Davies, Melanie
    Bode, Bruce W.
    Kushner, Robert F.
    Lewin, Andrew J.
    Skjoth, Trine V.
    Jensen, Christine B.
    Defronzo, Ralph A.
    DIABETES, 2014, 63 : A26 - A26
  • [42] Evaluation of weight change and cardiometabolic risk factors in a real-world population of US adults with overweight or obesity
    Pagidipati, Neha J.
    Mulder, Hillary
    Chiswell, Karen
    Lampron, Zachary
    Jones, William S.
    Machineni, Sriram
    Waitman, Lemuel R.
    Mongraw-Chaffin, Morgana
    Waterman, Fanta
    Kumar, Neela
    Ramasamy, Abhilasha
    Smolarz, Gabriel
    Peterson, Eric D.
    O'Brien, Emily
    PREVENTIVE MEDICINE, 2023, 170
  • [43] Changes in aldosterone and obesity-related cardiometabolic risk factors with a 1-year weight loss intervention in normotensive overweight and obese young adults
    Rossi, Gian Paolo
    Seccia, Teresa M.
    HYPERTENSION RESEARCH, 2013, 36 (10) : 856 - 858
  • [44] Changes in aldosterone and obesity-related cardiometabolic risk factors with a 1-year weight loss intervention in normotensive overweight and obese young adults
    Gian Paolo Rossi
    Teresa M Seccia
    Hypertension Research, 2013, 36 : 856 - 858
  • [45] Effects of a Web-Based Lifestyle Intervention on Weight Loss and Cardiometabolic Risk Factors in Adults With Overweight and Obesity: Randomized Controlled Clinical Trial
    Kohl, Jan
    Brame, Judith
    Centner, Christoph
    Wurst, Ramona
    Fuchs, Reinhard
    Sehlbrede, Matthias
    Tinsel, Iris
    Maiwald, Phillip
    Fichtner, Urs Alexander
    Armbruster, Christoph
    Farin-Glattacker, Erik
    Gollhofer, Albert
    Koenig, Daniel
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2023, 25
  • [46] Liraglutide, a Once-Daily Human GLP-1 Analogue, Reduces Body Weight and Improves Obesity-Related Risk Factors in Obese Non-Diabetic Subjects: a Randomized Placebo-Controlled Trial
    Astrup, Arne
    Van Gaal, Luc
    Rissanen, Aila
    Niskanen, Leo
    Al Hakim, Mazin
    Madsen, Jesper
    Rasmussen, Mads Frederik
    Rossner, Stephan
    OBESITY, 2008, 16 : S64 - S64
  • [47] Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial
    Garvey, W. Timothy
    Birkenfeld, Andreas L.
    Dicker, Dror
    Mingrone, Geltrude
    Pedersen, Sue D.
    Satylganova, Altynai
    Skovgaard, Dorthe
    Sugimoto, Danny
    Jensen, Camilla
    Mosenzon, Ofri
    DIABETES CARE, 2020, 43 (05) : 1085 - 1093
  • [48] Weight loss, exercise or both and cardiometabolic risk factors in obese older adults: results of a randomized controlled trial
    M Bouchonville
    R Armamento-Villareal
    K Shah
    N Napoli
    D R Sinacore
    C Qualls
    D T Villareal
    International Journal of Obesity, 2014, 38 : 423 - 431
  • [49] Weight loss, exercise or both and cardiometabolic risk factors in obese older adults: results of a randomized controlled trial
    Bouchonville, M.
    Armamento-Villareal, R.
    Shah, K.
    Napoli, N.
    Sinacore, D. R.
    Qualls, C.
    Villareal, D. T.
    INTERNATIONAL JOURNAL OF OBESITY, 2014, 38 (03) : 423 - 431
  • [50] A Whole-Grain Diet Reduces Cardiovascular Risk Factors in Overweight and Obese Adults: A Randomized Controlled Trial
    Kirwan, John P.
    Malin, Steven K.
    Scelsi, Amanda R.
    Kullman, Emily L.
    Navaneethan, Sankar D.
    Pagadala, Mangesh R.
    Haus, Jacob M.
    Filion, Julianne
    Godin, Jean-Philippe
    Kochhar, Sunil
    Ross, Alastair B.
    JOURNAL OF NUTRITION, 2016, 146 (11): : 2244 - 2251
12345